The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...
PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE DEVELOPMENT OF MASITINIB IN PROGRESSIVE FORMS OF MULTIPLE SCLEROSIS POST ECTRIMS 2024 Paris, 23 September 2024, 5.45pm CET AB Science SA (Euronext - ...
In other words, it marks healthy cells otherwise destroyed by multiple sclerosis, Type 1 diabetes or celiac disease. “These diseases like autoimmunity and allergy are usually treated by broad immune ...
Ms Corner said it shows "the part of John’s story that is rarely seen beyond his closest family" as he lies pensive in bed.
Gaps in access to care persist for US patients with MS and impact HRQOL to a large extent. Improving access to care for patients with MS should be prioritized.
Stay informed and make judicious decisions using our Ratings Table. Biogen and Idec merged in 2003, combining forces to ...
The totality of data from Sanofi clinical trials indicates that Tolebrutinib may target inflammation thought to contribute to ...
Columnist Desiree Lama has accepted her MS diagnosis as part of her identity — but it's not the only thing that defines her, ...
After years of caring for others, Auckland nurse Zazi Gohar faced her own health crisis when she was diagnosed with multiple ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback